losoxantrone has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, L; Higginson, LA; Huan, SD; Veinot, JP; Walley, VM; Walsh, SM | 1 |
| Finizio, M; Huan, SD; Natale, RB; Roberts, JD; Sartiano, GP; Stella, PJ; Stewart, DJ; Symes, AL | 1 |
1 trial(s) available for losoxantrone and Bone Cancer
| Article | Year |
|---|---|
A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anorexia; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Diarrhea; Drug Resistance, Neoplasm; Follow-Up Studies; Heart Ventricles; Hematologic Diseases; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Pyrazolones; Stomatitis; Survival Analysis; Vomiting | 2000 |
1 other study(ies) available for losoxantrone and Bone Cancer
| Article | Year |
|---|---|
Potential cardiotoxicity with the use of DuP-941: a case report.
Topics: Adult; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Fatal Outcome; Female; Heart; Heart Failure; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy; Microscopy, Electron; Myocardium; Myofibrils; Pyrazoles; Pyrazolones | 1995 |